SCHEMBL2657539

SCHEMBL2657539

Cc1cnc(NC(=O)c2cc(Oc3ccc(C(=O)N(C)C)cc3Cl)cc(OC3CCN(C)C3=O)c2)cn1

nearest known ligand 0.50

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCK P35557 20/20 0.50
KCNH2 Q12809 4/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2075079 1.00 GCK (0.50) GCKKCNH2
SCHEMBL2075229 0.89 GCK (0.52) GCKKCNH2
SCHEMBL2656841 0.84 GCK (0.55) GCKKCNH2
SCHEMBL2075777 0.84 GCK (0.55) GCKKCNH2
SCHEMBL2074639 0.82 GCK (0.56) GCK
SCHEMBL2659316 0.82 GCK (0.56) GCK
SCHEMBL2669608 0.79 GCK (0.38) GCKKCNH2
SCHEMBL2074921 0.79 GCK (0.65) GCKKCNH2
SCHEMBL2657879 0.79 GCK (0.65) GCKKCNH2
SCHEMBL2074397 0.79 GCK (0.66) GCKKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2086964-A2 BENZOYL AMINO HETEROCYCLYL COMPOUNDS USEFUL IN THE TREATMENT OF A DISEASE MEDIATED THROUGH GLK Astra Zeneca AB (SE) 2009-08-12 EP claimed
WO-2008050101-A2 BENZOYL AMINO HETEROCYCLYL COMPOUNDS USEFUL IN THE TREATMENT OF A DISEASE MEDIATED THROUGH GLK ASTRAZENECA AB (SE) 2008-05-02 WO claimed